Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Sygnature Discovery showcases its Bioscience expertise at ELRIG Drug Discovery 2017

Sygnature Discovery, the UK’s largest independent provider of integrated drug discovery resource and expertise, is showcasing the expertise of its BioScience department at ELRIG Drug Discovery 2017 In Liverpool from 3rd – 4th October 2017.

Drug Discovery 2017 is ELRIG’s flagship event. Now in its 11th year, the conference brings together the leading lights in drug discovery research across pharma, biotech, academia and the vendor community.  Below is a summary of the Sygnature activities at ELRIG Drug Discovery 2017:

Tuesday 3rd October 2017

ESSEN Workshop Presentation:

Dr Bryan Miller

“Use of live cell imaging assays for immuno-oncology in integrated drug discovery programmes”

09:35 – 9:55 – ROOM 11A

Snapshot Presentation:

Dr Marie Fisher

“Adoption of High-Content Imaging Capabilities in Support of Integrated Drug Discovery Programmes”

14.50 – 14.55

“Advances in Imaging” Session

Room – Hall 1B

Posters

  • Dr Bryan Miller (Poster #20): “Live cell and high-content imaging approaches to identify apoptosis inducers in cell models of triple negative breast cancer”
  • Ms Juliet Morgan (poster # 53): “Complementary biophysical approaches to assess fragment binding to the epigenetic target bromodomain-containing protein 3 (BRD3)
  • Dr Marie Fisher (poster #43): “Predicting drug-induced phospholipidosis using high resolution imaging in 2D and 3D cultures”
  • Dr Meera Raja (poster #1): “A phenotypic screen to identify novel neuroprotective agents”

Wednesday 4th October Time: 11.50

Poster spotlight presentation:

Dr Meera Raja

Track: Target ID & Validation

Room: Hall 1C

Latest News

View All

Sygnature Discovery moves US base to Kendall…

Sygnature Discovery raises over £2,776 for Cancer…

Sygnature Discovery named as Finalist in 2019…

Hidden chemistry in flowers shown to kill…

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.